Comments
Loading...
Iterum Therapeutics Stock Guidance | NASDAQ:ITRM | Benzinga
Iterum Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Iterum Therapeutics PLC (ITRM) does not provide guidance data | ||||||||||||
FAQ
What is the most recent guidance for Iterum Therapeutics (ITRM)?
There have been no specific sales or earnings guidance reported for Iterum Therapeutics in recent months.
Browse guidance and forecast on all stocks.
